Dynamic Technology Lab’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Dynamic Technology Lab’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,450	Closed	-$231K	–	1639
2021 Q3	$231K	Buy	+11,450	New	+$316K	0.03%	859
2020 Q4	–	Sell	-23,748	Closed	-$427K	–	1477
2020 Q3	$427K	Buy	+23,748	New	+$492K	0.07%	516

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Dynamic Technology Lab's DRNA Position: Q4 2021 in Review

Dynamic Technology Lab sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 11,450 shares — an estimated $231K sold.

Dynamic Technology Lab first reported a position in DRNA in Q3 2020 and held it in 2 quarters. The position peaked at $427K in Q3 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Dynamic Technology Lab reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Dynamic Technology Lab sold 11,450 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $231K.
Dynamic Technology Lab first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2020 and held it in 2 quarters.
Dynamic Technology Lab's Dicerna Pharmaceuticals, Inc. position peaked at $427K in Q3 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Dynamic Technology Lab's 13F filing for Q4 2021, filed 14 Feb 2022.